Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals

被引:43
作者
Takase, H
Yu, CR
Mahdi, RM
Douek, DC
DiRusso, GB
Midgley, FM
Dogra, R
Allende, G
Rosenkranz, E
Pugliese, A
Egwuagu, CE
Gery, I
机构
[1] NEI, NIH, Bethesda, MD 20892 USA
[2] Tokyo Med & Dent Univ, Grad Sch, Dept Ophthalmol & Visual Sci, Tokyo, Japan
[3] NIAID, NIH, Bethesda, MD 20892 USA
[4] Childrens Natl Med Ctr, Washington, DC 20010 USA
[5] Univ Miami, Diabet Res Inst, Immunogenet Program, Miami, FL 33136 USA
[6] Univ Miami, Div Cardiothorac Surg, Miami, FL 33136 USA
关键词
autoimmunity; retinal antigen; susceptibility to disease; tolerance; tumor immunity;
D O I
10.1093/intimm/dxh275
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The majority of maturing T lymphocytes that recognize self-antigens is eliminated in the thymus upon exposure to their target antigens. This physiological process of negative selection requires that tissue-specific antigens be expressed by thymic cells, a phenomenon that has been well studied in experimental animals. Here, we have examined the expression in human thymi of four retinal antigens, that are capable of inducing autoimmune ocular disease retinal S-antigen (S-Ag), recoverin, RPE65 and inter-photoreceptor retinoid-binding protein (IRBP)], as well as four melanocyte-specific antigens, two of which are used as targets for melanoma immunotherapy [gp100, melanoma antigen recognized by T cells 1, tyrosinase-related protein (TRP)-1 and TRP-2]. Using reverse transcription (RT)-PCR, we found that all thymic samples from the 18 donors expressed mRNA transcripts of most or all the eight tested tissue antigens. Yet, the expression of the transcripts varied remarkably among the individual thymic samples. In addition, S-Ag, RPE65 and IRBP were detected by immunostaining in rare cells in sections of human thymi by antibodies against these proteins. Quantitative real-time RT-PCR analysis revealed that the retinal antigen transcripts in the human thymus are present at trace levels, that are lower by approximately five orders of magnitude than those in the retina. Our observations thus support the notions that thymic expression is a common feature for all tissue-specific antigens and that the levels of expression play a role in determining the susceptibility to autoimmunity against these molecules.
引用
收藏
页码:1131 / 1140
页数:10
相关论文
共 38 条
  • [1] ADEMA GJ, 1994, J BIOL CHEM, V269, P20126
  • [2] High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: Mechanisms of selection of the self-reactive repertoire
    Anderson, AC
    Nicholson, LB
    Legge, KL
    Turchin, V
    Zaghouani, H
    Kuchroo, VK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) : 761 - 770
  • [3] Expression of self-antigen in the thymus: A little goes a long way
    Anderson, AC
    Kuchroo, VK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (11) : 1627 - 1629
  • [4] [Anonymous], 2002, MOL PATHOLOGY AUTOIM
  • [5] An immunologically privileged retinal antigen elicits tolerance: Major role for central selection mechanisms
    Avichezer, D
    Grajewski, RS
    Chan, CC
    Mattapallil, MJ
    Silver, PB
    Raber, JA
    Liou, GI
    Wiggert, B
    Lewis, GM
    Donoso, LA
    Caspi, RR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (11) : 1665 - 1676
  • [6] Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis
    Bielekova, B
    Sung, MH
    Kadom, N
    Simon, R
    McFarland, H
    Martin, R
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (06) : 3893 - 3904
  • [7] Complete sequence and polymorphism study of the human TYRP1 gene encoding tyrosinase-related protein 1
    Box, NF
    Wyeth, JR
    Mayne, CJ
    O'Gorman, LE
    Martin, NG
    Sturm, RA
    [J]. MAMMALIAN GENOME, 1998, 9 (01) : 50 - 53
  • [8] Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance -: The mechanism by which the IDDM2 locus may predispose to diabetes
    Chentoufi, AA
    Polychronakos, C
    [J]. DIABETES, 2002, 51 (05) : 1383 - 1390
  • [9] Adoptive-cell-transfer therapy for the treatment of patients with cancer
    Dudley, ME
    Rosenberg, SA
    [J]. NATURE REVIEWS CANCER, 2003, 3 (09) : 666 - U2
  • [10] Egwuagu CE, 1997, J IMMUNOL, V159, P3109